Equine Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

This report on the global equine healthcare market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global equine healthcare market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global equine healthcare market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global equine healthcare market.

Secondary research included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global equine healthcare market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global equine healthcare market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global equine healthcare market.

The report delves into the competition landscape of the global equine healthcare market. Key players operating in the global equine healthcare market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global equine healthcare market that have been profiled in this report.

Key Questions Answered in Equine Healthcare Market Report

What is the scope of growth of companies in the global equine healthcare market?
What will be the Y-o-Y growth of the global equine healthcare market between 2017 and 2028?
What is the influence of changing trends in technologies on the global equine healthcare market?
Which factors are anticipated to hamper the growth of the global equine healthcare market during the forecast period?
Which are the leading companies in the global equine healthcare market?

Research Methodology

A unique research methodology has been utilized to conduct comprehensive research on the growth of the global equine healthcare market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during production of the global equine healthcare market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of this study on the equine healthcare market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the equine healthcare market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global equine healthcare market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching estimates on future prospects of the global equine healthcare market more reliably and accurately.

Frequently Asked Questions about the Global Equine Healthcare Market

What is the estimated value of the Global Equine Healthcare Market?

The Global Equine Healthcare Market was estimated to be valued at $698.7 Million in 2021.

What is the growth rate of the Global Equine Healthcare Market?

The growth rate of the Global Equine Healthcare Market is 4.3%, with an estimated value of $972.8 Million by 2028.

What is the forecasted size of the Global Equine Healthcare Market?

The Global Equine Healthcare Market is estimated to be worth $972.8 Million by 2028.

Who are the key companies in the Global Equine Healthcare Market?

Key companies in the Global Equine Healthcare Market include Bayer AG (Bayer Animal Healthcare), Boehringer Ingelheim, Ceva Santé Animale, Eli Lilly and Company (Elanco), Equine Products U.K. Ltd., Merck & Co. (Merck Animal Healthcare), Sanofi (Merial), Purina Animal Nutrition LLC, Vetoquinol S.A. and Zoetis.

Report Attribute	Details
No. of Pages	244
Published	January 2022
Forecast Period	2021 - 2028
Estimated Market Value ( USD ) in 2021	$ 698.7 Million
Forecasted Market Value ( USD ) by 2028	$ 972.8 Million
Compound Annual Growth Rate	4.3%
Regions Covered	Global

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology3. Executive Summary: Global Equine Healthcare Market

4. Market Overview

4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Equine Healthcare Market Analysis and Forecast, 2017-2028
4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

5.1. Coagulation Disorders & Coagulation Pathways: Overview
5.2. Epidemiology: Coagulation Disorders
5.3. Regulatory Framework
5.4. Reimbursement Scenario
5.5. Equine Healthcare Market: Pricing Analysis
5.6. Equine Healthcare Market: Value Chain Analysis
5.7. Equine Healthcare Market: Porter’s Five Forces Analysis

6. Global Equine Healthcare Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Equine Healthcare Market Value Forecast, by Product Type, 2017-2028
6.2.1. Drugs
6.2.1.1. Anti-infectives
6.2.1.2. Anti-inflammatory
6.2.1.3. Parasiticides
6.2.1.4. Others
6.2.2. Vaccines
6.2.2.1. Inactivated
6.2.2.2. Live Attenuated
6.2.2.3. Recombinant
6.2.2.4. Others
6.2.3. Medical Supplemental Feed
6.2.3.1. Minerals
6.2.3.2. Vitamins
6.2.3.3. Protein
6.2.3.4. Enzyme
6.2.3.5. Others
6.3. Global Equine Healthcare Market Attractiveness Analysis, by Product Type

7. Global Equine Healthcare Market Analysis and Forecast, by Disease Type

7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Equine Healthcare Market Value Forecast, by Disease Type, 2017-2028
7.2.1. West Nile Virus
7.2.2. Equine Rabies
7.2.3. Potomac Horse Fever
7.2.4. Tetanus
7.2.5. Equine Influenza
7.2.6. Equine Herpes Virus
7.2.7. Equine Encephalomyelitis
7.2.8. Others (equine infectious anemia)
7.3. Global Equine Healthcare Market Attractiveness Analysis, by Disease Type

8. Global Equine Healthcare Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Equine Healthcare Market Value Forecast, by Distribution Channel, 2017-2028
8.2.1. Veterinary Hospitals & Clinics
8.2.2. Retail Pharmacies & Drug Stores
8.2.3. Others

9. Global Equine Healthcare Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Global Equine Healthcare Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Equine Healthcare Market Attractiveness Analysis, by Region

10. North America Equine Healthcare Market Analysis and Forecast

10.1. Introduction
10.1.1. Key Findings
10.2. North America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
10.2.1. Drugs
10.2.1.1. Anti-infectives
10.2.1.2. Anti-infectives
10.2.1.3. Anti-inflammatory
10.2.1.4. Parasiticides
10.2.1.5. Others
10.2.1.6. Transfer Lifts
10.2.1.7. Door Openers
10.2.1.8. Others
10.2.2. Vaccines
10.2.2.1. Inactivated
10.2.2.2. Live Attenuated
10.2.2.3. Recombinant
10.2.2.4. Others
10.2.2.5. Others
10.2.3. Medical Supplemental Feed
10.2.3.1. Minerals
10.2.3.2. Vitamins
10.2.3.3. Protein
10.2.3.4. Enzyme
10.2.3.5. Others
10.3. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
10.3.1. West Nile Virus
10.3.2. Equine Rabies
10.3.3. Potomac Horse Fever
10.3.4. Tetanus
10.3.5. Equine Influenza
10.3.6. Equine Herpes Virus
10.3.7. Equine Encephalomyelitis
10.3.8. Others (equine infectious anemia)
10.4. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
10.4.1. Veterinary Hospitals & Clinics
10.4.2. Retail Pharmacies & Drug Stores
10.4.3. Others
10.5. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Equine Healthcare Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Disease Type
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Equine Healthcare Market Analysis and Forecast

11.1. Introduction
11.1.1. Key Findings
11.2. Europe Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
11.2.1. Drugs
11.2.1.1. Anti-infectives
11.2.1.2. Anti-infectives
11.2.1.3. Anti-inflammatory
11.2.1.4. Parasiticides
11.2.1.5. Others
11.2.1.6. Transfer Lifts
11.2.1.7. Door Openers
11.2.1.8. Others
11.2.2. Vaccines
11.2.2.1. Inactivated
11.2.2.2. Live Attenuated
11.2.2.3. Recombinant
11.2.2.4. Others
11.2.2.5. Others
11.2.3. Medical Supplemental Feed
11.2.3.1. Minerals
11.2.3.2. Vitamins
11.2.3.3. Protein
11.2.3.4. Enzyme
11.2.3.5. Others
11.3. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
11.3.1. West Nile Virus
11.3.2. Equine Rabies
11.3.3. Potomac Horse Fever
11.3.4. Tetanus
11.3.5. Equine Influenza
11.3.6. Equine Herpes Virus
11.3.7. Equine Encephalomyelitis
11.3.8. Others (Equine Infectious Anemia)
11.4. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
11.4.1. Veterinary Hospitals & Clinics
11.4.2. Retail Pharmacies & Drug Stores
11.4.3. Others
11.5. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Equine Healthcare Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Disease Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Equine Healthcare Market Analysis and Forecast

12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
12.2.1. Drugs
12.2.1.1. Anti-infectives
12.2.1.2. Anti-infectives
12.2.1.3. Anti-inflammatory
12.2.1.4. Parasiticides
12.2.1.5. Others
12.2.1.6. Transfer Lifts
12.2.1.7. Door Openers
12.2.1.8. Others
12.2.2. Vaccines
12.2.2.1. Inactivated
12.2.2.2. Live Attenuated
12.2.2.3. Recombinant
12.2.2.4. Others
12.2.2.5. Others
12.2.3. Medical Supplemental Feed
12.2.3.1. Minerals
12.2.3.2. Vitamins
12.2.3.3. Protein
12.2.3.4. Enzyme
12.2.3.5. Others
12.3. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
12.3.1. West Nile Virus
12.3.2. Equine Rabies
12.3.3. Potomac Horse Fever
12.3.4. Tetanus
12.3.5. Equine Influenza
12.3.6. Equine Herpes Virus
12.3.7. Equine Encephalomyelitis
12.3.8. Others (equine infectious anemia)
12.4. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
12.4.1. Veterinary Hospitals & Clinics
12.4.2. Retail Pharmacies & Drug Stores
12.4.3. Others
12.5. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Equine Healthcare Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Disease Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Equine Healthcare Market Analysis and Forecast

13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
13.2.1. Drugs
13.2.1.1. Anti-infectives
13.2.1.2. Anti-infectives
13.2.1.3. Anti-inflammatory
13.2.1.4. Parasiticides
13.2.1.5. Others
13.2.1.6. Transfer Lifts
13.2.1.7. Door Openers
13.2.1.8. Others
13.2.2. Vaccines
13.2.2.1. Inactivated
13.2.2.2. Live Attenuated
13.2.2.3. Recombinant
13.2.2.4. Others
13.2.2.5. Others
13.2.3. Medical Supplemental Feed
13.2.3.1. Minerals
13.2.3.2. Vitamins
13.2.3.3. Protein
13.2.3.4. Enzyme
13.2.3.5. Others
13.3. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
13.3.1. West Nile Virus
13.3.2. Equine Rabies
13.3.3. Potomac Horse Fever
13.3.4. Tetanus
13.3.5. Equine Influenza
13.3.6. Equine Herpes Virus
13.3.7. Equine Encephalomyelitis
13.3.8. Others (equine infectious anemia)
13.4. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
13.4.1. Veterinary Hospitals & Clinics
13.4.2. Retail Pharmacies & Drug Stores
13.4.3. Others
13.5. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America Latin America
13.6. Latin America Equine Healthcare Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Disease Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
14.2.1. Drugs
14.2.1.1. Anti-infectives
14.2.1.2. Anti-infectives
14.2.1.3. Anti-inflammatory
14.2.1.4. Parasiticides
14.2.1.5. Others
14.2.1.6. Transfer Lifts
14.2.1.7. Door Openers
14.2.1.8. Others
14.2.2. Vaccines
14.2.2.1. Inactivated
14.2.2.2. Live Attenuated
14.2.2.3. Recombinant
14.2.2.4. Others
14.2.2.5. Others
14.2.3. Medical Supplemental Feed
14.2.3.1. Minerals
14.2.3.2. Vitamins
14.2.3.3. Protein
14.2.3.4. Enzyme
14.2.3.5. Others
14.3. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
14.3.1. West Nile Virus
14.3.2. Equine Rabies
14.3.3. Potomac Horse Fever
14.3.4. Tetanus
14.3.5. Equine Influenza
14.3.6. Equine Herpes Virus
14.3.7. Equine Encephalomyelitis
14.3.8. Others (equine infectious anemia)
14.4. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
14.4.1. Veterinary Hospitals & Clinics
14.4.2. Retail Pharmacies & Drug Stores
14.4.3. Others
14.5. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Equine Healthcare Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Disease Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share / Position Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Bayer AG (Bayer Animal Healthcare)
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Financial Analysis
15.4.1.3. Growth Strategies
15.4.1.4. SWOT Analysis
15.4.2. Boehringer Ingelheim
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Financial Analysis
15.4.2.3. Growth Strategies
15.4.2.4. SWOT Analysis
15.4.3. Ceva Santé Animale
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Financial Analysis
15.4.3.3. Growth Strategies
15.4.3.4. SWOT Analysis
15.4.4. Eli Lilly and Company (Elanco)
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Financial Analysis
15.4.4.3. Growth Strategies
15.4.4.4. SWOT Analysis
15.4.5. Equine Products U.K. Ltd.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Financial Analysis
15.4.5.3. Growth Strategies
15.4.5.4. SWOT Analysis
15.4.6. Merck & Co. (Merck Animal Healthcare)
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Financial Analysis
15.4.6.3. Growth Strategies
15.4.6.4. SWOT Analysis
15.4.7. Sanofi (Merial)
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Financial Analysis
15.4.7.3. Growth Strategies
15.4.7.4. SWOT Analysis
15.4.8. Purina Animal Nutrition LLC
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Financial Analysis
15.4.8.3. Growth Strategies
15.4.8.4. SWOT Analysis
15.4.9. Vetoquinol S.A.
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Financial Analysis
15.4.9.3. Growth Strategies
15.4.9.4. SWOT Analysis
15.4.10. Zoetis
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Financial Analysis
15.4.10.3. Growth Strategies
15.4.10.4. SWOT Analysis